Inventor · disambiguated record
Naoto Ueyama
Also filed as: UEYAMA NAOTO
9 granted patents·42 citations·filing 1987–2001
85Inventor score
Top patents by PatentIndex Score
9 records- 0161US6858724B2Non-mucin type synthetic compounds or its carrier conjugated compoundsKOTOBUKI PHARMACEUTICAL CO LTD·Filed 2001·Granted Feb 22, 2005·4 cites·16 claims
- 0261US6124460AIsoquinuclidine derivatives, method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compoundsKOTOBUKI PHARMACEUTICAL CO LTD·Filed 1999·Granted Sep 26, 2000·20 cites·19 claims
- 0349US5409947ACycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compoundsKOTOBUKI SEIYAKU CO LTD·Filed 1993·Granted Apr 25, 1995·9 cites·20 claims
- 0449US5008282ACyclic guanidine derivatives, anti-ulceratives and methods of manufacturing the sameKOTOBUKI SEIYAKU CO LTD·Filed 1989·Granted Apr 16, 1991·3 cites·9 claims
- 0548US5527815ACarboxymethylidenecycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compoundsKOTOBUKI SEIYAKU CO LTD·Filed 1994·Granted Jun 18, 1996·3 cites·22 claims
- 0645US6316634B2Method for preparing cycloheptimidazolesKOTOBUKI PHARMACEUTICAL CO LTD·Filed 2001·Granted Nov 13, 2001·0 cites·1 claims
- 0745US6278027B13-Substituted-2-halocycloheptenone compounds and a method for manufacturing sameKOTOBUKI PHARMACEUTICAL CO LTD·Filed 1999·Granted Aug 21, 2001·2 cites·4 claims
- 0837US5240944ACyclic guanidine derivatives, anti-ulceratives and method of manufacturing the sameKOTOBUKI SEIYAKU CO LTD·Filed 1991·Granted Aug 31, 1993·1 cites·5 claims
- 0930US4780462AAntihypertensive 1,5-benzothiazepine derivatives and compositions thereofKOTOBUKI SEIYAKU CO LTD·Filed 1987·Granted Oct 25, 1988·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Naoto Ueyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →